Видео ютуба по тегу Krista Lanctot

Krista Lanctot, PhD: Nabilone Significantly Improves Agitation in Alzheimer Disease
Krista Lanctot, PhD: Nabilone Significantly Improves Agitation in Alzheimer Disease
Krista Lanctot, PhD: Treating Agitation in Alzheimer Disease
Krista Lanctot, PhD: Treating Agitation in Alzheimer Disease
Krista Lanctot, PhD: Managing Patients with Agitation
Krista Lanctot, PhD: Managing Patients with Agitation
Krista Lanctot, PhD: Addressing Alzheimer Disease Agitation
Krista Lanctot, PhD: Addressing Alzheimer Disease Agitation
AM1 Managing Behavioural Symptoms of Dementia and Mental Illness - Krista Lanctot
AM1 Managing Behavioural Symptoms of Dementia and Mental Illness - Krista Lanctot
Krista Lanctot, PhD - supported by Cures Within Reach
Krista Lanctot, PhD - supported by Cures Within Reach
Apathy and Alzheimer’s Disease: Plenary Preview with Dr. Krista Lanctôt
Apathy and Alzheimer’s Disease: Plenary Preview with Dr. Krista Lanctôt
Dr Krista Lanctôt - CIHR Training Program in Neurodegenerative Lipidomics
Dr Krista Lanctôt - CIHR Training Program in Neurodegenerative Lipidomics
Mental Health associations & impacts on recovery from stroke, heart conditions & VCI
Mental Health associations & impacts on recovery from stroke, heart conditions & VCI
Measuring clinically relevant change in apathy symptoms in AD using data from the ADMET trials
Measuring clinically relevant change in apathy symptoms in AD using data from the ADMET trials
Predicting Response to Cannabinoid Treatment for Agitation in Alzheimer Disease
Predicting Response to Cannabinoid Treatment for Agitation in Alzheimer Disease
A study investigating nabilone for the treatment of agitation in AD
A study investigating nabilone for the treatment of agitation in AD
Biomarkers of apathy in Alzheimer’s disease
Biomarkers of apathy in Alzheimer’s disease
The prodromal phases of Alzheimer’s disease
The prodromal phases of Alzheimer’s disease
National ECHO Fall 2024: Dementia-related Apathy (Session 9)
National ECHO Fall 2024: Dementia-related Apathy (Session 9)
Impact of Alzheimer's disease treatments on apathy
Impact of Alzheimer's disease treatments on apathy
Pharmacological management of agitation in Alzheimer’s dementia
Pharmacological management of agitation in Alzheimer’s dementia
Диагностика и лечение апатии, связанной с деменцией: последние достижения
Диагностика и лечение апатии, связанной с деменцией: последние достижения
Apathy in dementia
Apathy in dementia
Denis and Rhonda Lanctot Krista Touesnard Fiddle
Denis and Rhonda Lanctot Krista Touesnard Fiddle
New diagnostic criteria for apathy in neurocognitive disorders
New diagnostic criteria for apathy in neurocognitive disorders
Understanding agitation in Alzheimer’s disease and current approaches to management
Understanding agitation in Alzheimer’s disease and current approaches to management
Exploring Novel Drug Treatments for Agitation in Alzheimer’s Disease
Exploring Novel Drug Treatments for Agitation in Alzheimer’s Disease
Using RNNs to Analyse Visual Scanning Behaviour to Detect Apathy in Alzheimer Patients
Using RNNs to Analyse Visual Scanning Behaviour to Detect Apathy in Alzheimer Patients